Downregulation of Retinal Connexin 43 in GFAP-Expressing Cells Modifies Vasoreactivity Induced by Perfusion Ocular Pressure Changes.
Animals
Blood Pressure
/ physiology
Blotting, Western
Connexin 43
/ genetics
Dependovirus
/ genetics
Down-Regulation
Gene Expression Regulation
/ physiology
Glial Fibrillary Acidic Protein
/ genetics
Immunohistochemistry
Intraocular Pressure
/ physiology
Male
Microscopy, Confocal
Ophthalmoscopy
Rats
Rats, Inbred BN
Regional Blood Flow
Retina
/ metabolism
Retinal Artery
/ physiology
Retinal Vein
/ physiology
Transfection
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
04 01 2021
04 01 2021
Historique:
entrez:
27
1
2021
pubmed:
28
1
2021
medline:
12
6
2021
Statut:
ppublish
Résumé
Glia and their communication via connexin 43 (Cx43) gap junctions are known to mediate neurovascular coupling, a process driven by metabolic demand. However, it is unclear whether Cx43 mediated glial communication intermediates classical autoregulation. Here we used viral transfection and a glial fibrillary acidic protein (GFAP) promoter to downregulate glial Cx43 to evaluate its role in retinal vascular autoregulation to ocular perfusion pressure (OPP) reduction. Adult rats were intravitreally injected with the viral active construct or a control. Three weeks after the injection, eyes were imaged using confocal scanning laser ophthalmoscopy before and during a period of OPP decrease induced by blood draw to lower blood pressure or by manometric IOP elevation. Vessel diameter responses to the OPP decrease were compared between Cx43-downregulated and control-injected eyes. The extent of Cx43 downregulation was evaluated by Western blot and immunohistochemistry. In control eyes, the OPP decrease induced dilatation of arterioles, but not venules. In Cx43-downregulated eyes, Cx43 expression in whole retina was decreased by approximately 40%. In these eyes, the resting diameter of the venules increased significantly, but there was no effect on arterioles. In Cx43-downregulated eyes, vasoreactivity evoked by blood pressure lowering was significantly compromised in both arterioles (P = 0.005) and venules (P = 0.001). Cx43 downregulation did not affect the arteriole responses to IOP elevation, whereas the responses of the venules showed a significantly greater decrease in diameter (P < 0.001). The downregulation of retinal Cx43 in GFAP-expressing cells compromises vasoreactivity of both arterioles and venules in response to an OPP decrease achieved via blood pressure lowering or IOP elevation. The results also suggest that Cx43-mediated glial communication actively regulates resting venular diameter.
Identifiants
pubmed: 33502459
pii: 2772223
doi: 10.1167/iovs.62.1.26
pmc: PMC7846954
doi:
Substances chimiques
Connexin 43
0
GFAP protein, rat
0
Gja1 protein, rat
0
Glial Fibrillary Acidic Protein
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
26Subventions
Organisme : NEI NIH HHS
ID : R01 EY019939
Pays : United States
Références
Graefes Arch Clin Exp Ophthalmol. 1997 Oct;235(10):618-26
pubmed: 9349945
PLoS One. 2013 Sep 27;8(9):e76310
pubmed: 24086725
Nature. 2020 Sep;585(7823):91-95
pubmed: 32788726
Invest Ophthalmol Vis Sci. 2012 Jun 20;53(7):3726-32
pubmed: 22589427
Physiol Rev. 2006 Jul;86(3):1009-31
pubmed: 16816144
Biomed Res Int. 2016;2016:2954721
pubmed: 27294114
Invest Ophthalmol Vis Sci. 2011 Apr 05;52(5):2153-9
pubmed: 21220555
J Neurosci. 2015 May 27;35(21):8245-57
pubmed: 26019339
Exp Eye Res. 2004 Sep;79(3):423-9
pubmed: 15336506
Antioxid Redox Signal. 2009 Feb;11(2):267-82
pubmed: 18834327
Am J Physiol Cell Physiol. 2017 Oct 1;313(4):C362-C370
pubmed: 28974518
Science. 2001 May 4;292(5518):872-3
pubmed: 11341285
Panminerva Med. 2017 Mar;59(1):76-89
pubmed: 27598891
J Neurosurg. 2014 Mar;120(3):628-38
pubmed: 24266544
Neuroscience. 1999;92(1):255-65
pubmed: 10392848
Optom Vis Sci. 2019 Jul;96(7):470-476
pubmed: 31274734
J Neurosci. 2015 Sep 30;35(39):13463-74
pubmed: 26424891
Nature. 2010 Nov 11;468(7321):232-43
pubmed: 21068832
Glia. 2006 Nov 15;54(7):716-25
pubmed: 17006900
PLoS One. 2014 Dec 11;9(12):e114546
pubmed: 25501362
Acta Neurol Belg. 2004 Jun;104(2):51-6
pubmed: 15508267
PLoS One. 2010 Aug 24;5(8):e12387
pubmed: 20808778
Microvasc Res. 2015 Sep;101:86-95
pubmed: 26186381
Trends Neurosci. 2013 Jul;36(7):405-17
pubmed: 23659852
Philos Trans R Soc Lond B Biol Sci. 2015 Jul 5;370(1672):
pubmed: 26009774
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Clin Sci (Lond). 1999 Apr;96(4):313-26
pubmed: 10087237
Physiol Rep. 2013 Aug;1(3):e00055
pubmed: 24303137
Surv Ophthalmol. 1994 Jul-Aug;39(1):23-42
pubmed: 7974188
Epilepsia. 2011 Mar;52(3):589-601
pubmed: 21275977
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):1-8
pubmed: 28055098
Glia. 1997 May;20(1):10-22
pubmed: 9145301
Clin Exp Ophthalmol. 2001 Jun;29(3):167-70
pubmed: 11446461
Arch Mal Coeur Vaiss. 2005 Sep;98(9):913-21
pubmed: 16231579
Exp Eye Res. 2010 Feb;90(2):203-9
pubmed: 19853603
Prog Retin Eye Res. 2016 Mar;51:41-68
pubmed: 26432657
J Glaucoma. 1996 Oct;5(5):308-10
pubmed: 8897229
Front Neuroenergetics. 2013 Apr 26;5:4
pubmed: 23637659
Invest Ophthalmol Vis Sci. 2014 May 29;55(7):4105-18
pubmed: 24876284
Compr Physiol. 2012 Jul;2(3):1981-2035
pubmed: 23723031
J Comp Neurol. 2003 Jan 20;455(4):531-46
pubmed: 12508325
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7551-9
pubmed: 26618647
Vis Neurosci. 2006 Jan-Feb;23(1):1-10
pubmed: 16597346
Invest Ophthalmol Vis Sci. 2016 Feb;57(2):412-9
pubmed: 26848880
Nature. 2009 Feb 5;457(7230):675-7
pubmed: 19194443
Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1019-25
pubmed: 8125712
Microvasc Res. 1997 May;53(3):211-21
pubmed: 9211399
Biomed Opt Express. 2012 Sep 1;3(9):2220-33
pubmed: 23024915
J Comp Neurol. 1991 Nov 22;313(4):587-603
pubmed: 1783683
Ophthalmic Physiol Opt. 2015 Mar;35(2):114-24
pubmed: 25528886
PLoS One. 2017 Dec 15;12(12):e0188830
pubmed: 29244806
Microcirculation. 1996 Sep;3(3):263-70
pubmed: 8930883
Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2855-63
pubmed: 18456724
Biomed Opt Express. 2013 Feb 1;4(2):364-86
pubmed: 23412846